Summary:
- The article discusses a draft guidance from the National Institute for Health and Care Excellence (NICE) in the UK, recommending the use of the medication semaglutide to prevent heart attacks and strokes in adults who have previously had a heart attack, stroke, or peripheral arterial disease.
- Semaglutide is a type of medication called a GLP-1 agonist, which helps to lower blood sugar levels and can also have beneficial effects on the heart and blood vessels.
- The guidance suggests that semaglutide could be an important new treatment option for people at high risk of heart and circulatory problems, potentially helping to reduce their chances of having another heart attack or stroke.